Anemia, a condition characterized by a deficiency of red blood cells or hemoglobin, is a prevalent issue in clinical practice. Its multifactorial etiology requires a thorough and systematic diagnostic approach to determine the underlying cause and appropriate treatment.
The initial evaluation of anemia should include a comprehensive medical history and physical examination. This will help identify any potential symptoms such as fatigue, pallor, or dyspnea, as well as any clinical signs such as jaundice or splenomegaly. Additionally, a complete blood count (CBC) should be obtained to assess the severity of the anemia and provide clues to its cause.
Classification of anemia based on the mean corpuscular volume (MCV) helps narrow down the differential diagnosis. Microcytic anemia suggests iron deficiency, thalassemia, or anemia of chronic disease. Normocytic anemia may indicate acute blood loss, hemolysis, or renal disease. Macrocytic anemia suggests vitamin B12 or folate deficiency, myelodysplastic syndrome, or alcohol abuse.
Further diagnostic testing should be guided by the initial evaluation and MCV classification. Iron studies, reticulocyte count, hemoglobin electrophoresis, vitamin B12 and folate levels, and bone marrow biopsy may be necessary depending on the suspected cause. It is essential to consider the patient's demographics, comorbidities, and potential exposure to toxins or medications that could contribute to anemia.
Unraveling the complexities of anemia requires a comprehensive diagnostic approach that integrates clinical evaluation with laboratory testing. By systematically classifying and investigating anemia, healthcare professionals can accurately diagnose the underlying cause and initiate appropriate treatment. This approach not only addresses the anemia itself but also potentially uncovers other significant health conditions that may otherwise remain undetected.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation